港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

医美概念股

617.392

+1.4820.24%

涨家数：4

跌家数：6

平家数：3

市盈率：- -

高：633.963

开：614.939

低：614.939

收：615.910

数据加载中...

三生制药盘中异动快速上涨5.00%报7.140港元

三生制药(01530)上涨5.0%，报7.14元/股

昊海生物科技盘中异动下午盘快速上涨5.15%报27.550港元

四环医药盘中异动股价大涨5.08%

复星医药获控股股东复星高科技质押3000万股

复星医药(02196)获控股股东复星高科技质押3000万股

去年和复星医药“分手”！这家创新药企要再冲IPO！但亏损依旧……

换了四任保荐机构！五次备案！现在中金出马，沪鸽IPO这回能成功吗？

IPO日报国际金...

四环医药02月25日遭主力抛售182万元

山河药辅1月完成回购，股东2月宣布减持，复星医药已累计套现超1.2亿

瑞丽医美盘中异动下午盘快速上涨6.80%

招银国际：内地药品价格政策有望优化医疗AI加速商业化落地

医美狂飙50%+，创新药管线收获在即，解码四环医药（0460.HK）的双增长极逻辑

医思健康盘中异动早盘股价大跌5.41%报0.700港元

郭广昌：关于AI，未来特别看好两个方向

聚焦创新与国际化发展，上海生物医药行业迈入集群化、高质量发展新阶段

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1593/news?page=8"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"医美概念股","latestPrice":617.3917,"timestamp":1741579196667,"preClose":615.91016,"halted":0,"volume":56964274,"delay":0,"changeRate":0.002405,"change":1.481567,"pbRate":1.190795,"amount":423752459,"amplitude":0.030888,"prevYearClose":571.87146,"fiveDayClose":604.125,"twentyDayClose":578.349,"turnoverRate":0.002844,"marketCap":111104330656,"floatMarketCap":73448326880,"peRate":21.56404},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":633.96344,"amplitude":0.030888,"preClose":615.91016,"low":614.9391,"pbRate":"1.190795","latestPrice":617.3917,"volume":56964274,"delay":0,"open":614.9391,"prevYearClose":571.87146,"prevWeekClose":615.91,"prevMonthClose":612.07,"prevQuarterClose":571.871,"fiveDayClose":604.125,"twentyDayClose":578.349,"sixtyDayClose":582.226,"secType":"PLATE","market":"HK","turnoverRate":0.002844,"peRate":21.56404,"marketCap":111104330656,"floatMarketCap":73448326880,"timestamp":1741579196667,"nameCN":"医美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":4,"down":6,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:16,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514500897","title":"三生制药盘中异动 快速上涨5.00%报7.140港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514500897","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514500897?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 13:53","pubTimestamp":1740549194,"startTime":"0","endTime":"0","summary":"2025年02月26日下午盘13时53分，三生制药股票出现波动，股价急速拉升5.00%。截至发稿，该股报7.140港元/股，成交量1437.75万股，换手率0.60%，振幅6.18%。资金方面，该股资金流入6084.78万港元，流出2286.93万港元。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。三生制药股票所在的药品行业中，整体涨幅为0.50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261353159630c12f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261353159630c12f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01530","BK1583","BK1593"],"gpt_icon":0},{"id":"2514008651","title":"三生制药(01530)上涨5.0%，报7.14元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2514008651","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514008651?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 13:53","pubTimestamp":1740549193,"startTime":"0","endTime":"0","summary":"2月26日，三生制药(01530)盘中上涨5.0%，截至13:53，报7.14元/股，成交1.0亿元。三生制药是一家主要致力于开发、生产和销售医药产品，产品包括重组人血小板生成素、肿瘤坏死因子α抑制剂以及重组人促红素等，销售市场涵盖国内以及斯里兰卡、多米尼加共和国和泰国等海外市场。此外，公司通过其子公司集思有限公司,香港三生医疗有限公司和沈阳三生制药有限责任公司也从事项目管理和咨询业务。截至2024年中报，三生制药营业总收入43.89亿元、净利润10.9亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/26135348396180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1593","BK1161","01530","BK1583"],"gpt_icon":0},{"id":"2514900811","title":"昊海生物科技盘中异动 下午盘快速上涨5.15%报27.550港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514900811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514900811?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 13:51","pubTimestamp":1740549063,"startTime":"0","endTime":"0","summary":"2025年02月26日下午盘13时51分，昊海生物科技股票出现异动，股价急速上涨5.15%。截至发稿，该股报27.550港元/股，成交量38.252万股，换手率0.98%，振幅5.73%。资金方面，该股资金流入484.368万港元，流出319.737万港元。昊海生物科技股票所在的医疗设备及用品行业中，整体涨幅为0.13%。其相关个股中，先健科技、昊海生物科技、爱康医疗涨幅较大，振幅较大的相关个股有润迈德-B、堃博医疗-B、微创机器人-B，振幅分别为21.92%、9.09%、8.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261351039630c09c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261351039630c09c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06826","BK1593"],"gpt_icon":0},{"id":"2514637020","title":"四环医药盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514637020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514637020?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 09:48","pubTimestamp":1740534480,"startTime":"0","endTime":"0","summary":"2025年02月26日早盘09时48分，四环医药股票出现波动，股价快速拉升5.08%。四环医药股票所在的药品行业中，整体涨幅为0.01%。其相关个股中，华控康泰、三爱健康集团、德琪医药-B涨幅较大，振幅较大的相关个股有德琪医药-B、李氏大药厂、和黄医药，振幅分别为6.76%、4.03%、3.83%。最新业绩公告指出，2024年公司医美板块收入增速保持不低于50%。自Sylfirm X双波射频获批上市后，品牌影响力持续扩大。紧接着在2月11日，四环宣布以572万港元回购1000万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226094800abdd19f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226094800abdd19f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1600","BK1191","BK1515","BK1593","00460"],"gpt_icon":0},{"id":"2514021635","title":"复星医药获控股股东复星高科技质押3000万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2514021635","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514021635?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 08:46","pubTimestamp":1740530760,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　复星医药（02196）发布公告，公司于2025年2月25日接到控股股东上海复星高科技（集团）有限公司（简称“复星高科技”）的通知，其已将所持有公司的部分A股股份办理质押手续，本次质押股份数量为3000万股。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-02-26/doc-inemukxr9084502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600196","BK0012","BK0096","BK0183","BK1191","BK0188","BK0060","BK1593","BK0196","02196","BK0239","BK1515","BK0028","BK0187","BK0175"],"gpt_icon":0},{"id":"2514984060","title":"复星医药(02196)获控股股东复星高科技质押3000万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2514984060","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514984060?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 19:45","pubTimestamp":1740483900,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)发布公告，公司于2025年2月25日接到控股股东上海复星高科技(集团)有限公司(简称“复星高科技”)的通知，其已将所持有公司的部分A股股份办理质押手续，本次质押股份数量为3000万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254231.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK1191","BK1515","BK0060","BK0096","BK1593","02196","BK0175","BK0187","BK0188","BK0239","600196","BK0012","BK0183","BK0196"],"gpt_icon":0},{"id":"2514067150","title":"去年和复星医药“分手”！这家创新药企要再冲IPO！但亏损依旧……","url":"https://stock-news.laohu8.com/highlight/detail?id=2514067150","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514067150?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 19:15","pubTimestamp":1740482100,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　时隔两年半，真实生物科技有限公司再次向港交所申请主板上市。　　此前，真实生物的产品阿兹夫定于2022年7月附条件获批，成为首款获批上市的国产新冠肺炎口服药物。　　紧接着，获批十天后，真实生物于2022年8月4日首次向港交所递交了招股书，引发市场巨大关注。但是，真实生物的首次赴港路却以失败告终。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hyyj/2025-02-25/doc-inemtccz1114606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","BK0096","06978","BK0183","02196","BK0012","BK0187","BK1593","BK0175","BK0060","BK0188","159992","BK1161","BK1515","BK0196","BK0239","BK0028","600196","BK1574"],"gpt_icon":0},{"id":"2514060442","title":"换了四任保荐机构！五次备案！现在中金出马，沪鸽IPO这回能成功吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2514060442","media":"IPO日报国际金...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514060442?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 19:15","pubTimestamp":1740482100,"startTime":"0","endTime":"0","summary":"2021年12月，沪鸽申请创业板IPO受理，接受一轮问询，随后又于2022年8月申请终止上市。2022年9月，沪鸽上市辅导再次进行了备案，辅导机构为中原证券，随后则因撤回辅导备案而终止。自此，历经六年，沪鸽频繁更换四任保荐券商，接受了五次上市辅导备案，但连A股上市的龙门都没有见到。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/cj/2025-02-25/doc-inemtcea8841827.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","BK1587","BK1583","BK1593","159982","06699","399300"],"gpt_icon":0},{"id":"2514507510","title":"四环医药02月25日遭主力抛售182万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514507510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514507510?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 16:17","pubTimestamp":1740471429,"startTime":"0","endTime":"0","summary":"02月25日, 四环医药股价跌4.84%，报收0.59元，成交金额751万元，换手率0.13%，振幅4.84%，量比0.57。四环医药今日主力资金净流出182万元，连续7日净流出，上一交易日主力净流出28万元。该股近5个交易日下跌3.28%，主力资金累计净流出411万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入644万元，其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225165009abdc1eee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225165009abdc1eee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","00460","BK1593","BK1600"],"gpt_icon":0},{"id":"2514051893","title":"山河药辅1月完成回购，股东2月宣布减持，复星医药已累计套现超1.2亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2514051893","media":"时代周报","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514051893?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 15:45","pubTimestamp":1740469516,"startTime":"0","endTime":"0","summary":"作者：梁怡山河药辅（300542.SZ）再遭股东复星医药（600196.SH）减持。2月24日，山河药辅公告，股东上海复星医药产业发展有限公司（以下简称：复星产业）因经营需要，计划以集中竞价和大宗交易方式合计减持公司股份不超过697.8万股，即不超过公司总股本的3%。复星产业是复星医药的全资子公司，主要从事医药企业的股权投资等业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502253328956490.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1593","02196","BK1191","BK1515"],"gpt_icon":0},{"id":"2514034798","title":"瑞丽医美盘中异动 下午盘快速上涨6.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514034798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514034798?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 13:41","pubTimestamp":1740462089,"startTime":"0","endTime":"0","summary":"2025年02月25日下午盘13时41分，瑞丽医美股票出现波动，股价大幅上涨6.80%。截至发稿，该股报0.110港元/股，成交量125.267万股，换手率0.22%，振幅6.80%。瑞丽医美股票所在的医疗及医学美容服务行业中，整体跌幅为1.00%。其相关个股中，现代健康科技、瑞丽医美、天元医疗涨幅较大，振幅较大的相关个股有天元医疗、现代健康科技、一脉阳光，振幅分别为57.69%、16.05%、12.99%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502251341299891c177&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502251341299891c177&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1209","02135","BK1593"],"gpt_icon":0},{"id":"2514129084","title":"招银国际：内地药品价格政策有望优化 医疗AI加速商业化落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2514129084","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514129084?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 09:50","pubTimestamp":1740448233,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招银国际发布研报称，维持内地医药行业“优于大市评级”。MSCI中国医疗指数2025年初至今累计上涨11.5%，跑输MSCI中国指数1.2%。受益于国内药品价格政策优化、国内宏观环境改善以及海外降息预期，医药行业有望在2025年继续迎来估值修复。报告指，丙类医保目录年内即将落地，创新药将覆盖获得更好的支付环境；医疗设备招标加速复苏，将推动国产医疗设备企业盈利复苏。该行看好行业估值修复，推荐买入信达生物(01801)、百济神州(06160)、三生制药(01530)、联影医疗(688271.SH)、巨子生物(02367)、药明康德(02359)、科伦博泰生物-B(06990)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253807.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2328871848.SGD","BK1576","LU0588546209.SGD","02359","BK1141","LU2488822045.USD","LU1046422090.SGD","BK1593","01801","LU2125910500.SGD","LU0320764599.SGD","BK1161","01530","BK1500","BK1589","LU0708995583.HKD","150261","LU2242644610.SGD","BK1583","BK1588","LU2045819591.USD","02367","LU0052750758.USD","LU0307460666.USD","BK1207","06160","LU1969619763.USD"],"gpt_icon":0},{"id":"2514846290","title":"医美狂飙50%+，创新药管线收获在即，解码四环医药（0460.HK）的双增长极逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2514846290","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514846290?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 09:42","pubTimestamp":1740447738,"startTime":"0","endTime":"0","summary":"2024年公司医美板块收入增速保持不低于50%。","market":"us","thumbnail":"https://img7.gelonghui.com/column/6.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/6.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1805447","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1161","BK1191","00460","06978","BK1600","BK1574","BK1515","BK1593"],"gpt_icon":0},{"id":"2514108406","title":"医思健康盘中异动 早盘股价大跌5.41%报0.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514108406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514108406?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 09:38","pubTimestamp":1740447515,"startTime":"0","endTime":"0","summary":"2025年02月25日早盘09时38分，医思健康股票出现异动，股价快速下跌5.41%。截至发稿，该股报0.700港元/股，成交量21.5万股，换手率0.02%，振幅2.70%。资金方面，该股资金流入0港元，流出15.053万港元。医思健康股票所在的医疗及医学美容服务行业中，整体跌幅为0.68%。其相关个股中，宏力医疗管理、熙康云医院、亮晴控股涨幅较大，振幅较大的相关个股有平安好医生、希玛医疗、瑞尔集团，振幅分别为5.99%、5.50%、4.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225093835962f2aad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225093835962f2aad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1215","02138","BK1593","BK1511"],"gpt_icon":0},{"id":"2513744139","title":"郭广昌：关于AI，未来特别看好两个方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2513744139","media":"新京报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513744139?lang=zh_cn&edition=fundamental","pubTime":"2025-02-24 19:21","pubTimestamp":1740396060,"startTime":"0","endTime":"0","summary":"“未来，我特别看好两个方向，一是AI赋能各垂直行业进行行业的再造与升级，另一个是物理AI与虚拟AI真正结合对生产力和生产关系产生的革命性变化。”郭广昌认为，在当前环境下，找一个行业从头做起的机会越来越少，要聚集优势产业做深做透。对复星而言，未来仍然是聚焦大健康、旅文、消费等优势产业“深挖矿”，依靠产业运营能力，用“手艺活”赚钱，依靠创新和全球化，深耕国内和全球市场，全面融入AI提升效率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224192222a251dabd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224192222a251dabd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600196","BK1230","BK1191","02196","00656","BK1515","BK1593"],"gpt_icon":0},{"id":"2513714095","title":"聚焦创新与国际化发展，上海生物医药行业迈入集群化、高质量发展新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2513714095","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513714095?lang=zh_cn&edition=fundamental","pubTime":"2025-02-24 16:07","pubTimestamp":1740384476,"startTime":"0","endTime":"0","summary":"此次大会的召开，标志着上海生物医药行业将不断迈入集群化、高质量发展新阶段。陈启宇会长在任职演讲中表示，成立上海市工商联生物医药商会不仅是上海生物医药行业的里程碑，更是推动行业高质量发展的新起点。上海已汇聚一大批优秀的民营生物医药企业，创新与国际化发展大有可为。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022416061398908903&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022416061398908903&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","02196","600196","BK1593"],"gpt_icon":0}],"pageSize":16,"totalPage":9,"pageCount":8,"totalSize":136}]}}